Latest

Feb 12, 2018
Pharm Exec speaks to Jane Griffiths, Global Head of Actelion, about the current state of the industry's reputation and the work that needs to be done to further build trust with patients and the public.
Feb 08, 2018
Commissioner Scott Gottlieb this week outlined FDA plans to continue the fight against opioid addiction and to prepare a “comprehensive plan” to bolster the market for biosimilars.
Feb 03, 2018
The UK's NICE now has the job of both being a member of the newly named Accelerated Access Collaborative (AAC) and also acting as its Secretariat.
Feb 02, 2018
Pharmaceutical Executive
2017 was a year of swings and momentum for the pharma and biotech markets. Is more stable footing ahead? Peter Young reports.
Feb 02, 2018
Achieving proper security in industries like life sciences and healthcare, where web-based systems and internal networks are late in coming, may seem a daunting task. But it shouldn't be, writes Dr. Jeff R. Livingstone.
Feb 01, 2018
Payers and pharma must shift away from the traditional one drug–one price approach and expand "indication-based pricing", writes Anaïs Frappé.
Jan 30, 2018
Vickie Andros and Jake Caines discuss how to identify and overcome barriers that keep prescriptions from getting to the pharmacy, and most importantly, to the patient.
Jan 29, 2018
Outlining the procedures to manage anti-corruption risk that life sciences companies should consider before doing business in China.
Jan 19, 2018
Darcee Strube offers an overview of the key issues and progress made in dermatology biologics.
Jan 18, 2018
Rachel Howard makes the case for pharmaceutical companies to include the developing world front and centre in their vision.
native1_300x100
lorem ipsum